• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    More On OASM

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Oasmia Pharmaceutical AB (publ) (OASM)

    -NasdaqCM
    3.29 Down 0.31(8.61%) Jun 24, 3:56PM EDT
    Prev Close:3.60
    Open:3.25
    Bid:1.00 x 500
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:3.17 - 3.30
    52wk Range:2.75 - 5.25
    Volume:2,935
    Avg Vol (3m):25,405
    Market Cap:117.57M
    P/E (ttm):N/A
    EPS (ttm):-0.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OASM

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):46.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oasmia Pharmaceutical AB (publ) researches, develops, and manufactures drugs for human and veterinary oncology primarily in Sweden. It focuses on manufacturing formulations based on cytostatics. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback